Giving surgeons clarity on margins
to act in the momentand close with confidence.

Giving surgeons clarity on margins
to act in the momentand close with confidence.

The Time to Know is Now

Perimeter OCT Margin Imaging Technology

Re-excision surgeries due to positive margins are all too common. Surgeons need to know whether they have achieved clean margins during the initial surgery.

Harnessing the power of advanced technology, Perimeter Medical Imaging is driven to transform cancer surgery with advanced imaging tools. The Perimeter Optical Coherence Tomography (OCT) system provides high-resolution imaging to help cancer1 surgeons get clean margins in real time – when it matters most.

See the Benefits

The S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. More information here.

OCT is an evidence-based technology that can potentially reduce the likelihood of patients having to return for another surgery.

Amani Jambhekar, MD, MBA, FACS

The S-Series OCT has a general indication and has not been evaluated by FDA for specific uses. More information here.

WEBINAR RECORDING: Clearer Margins. Greater Confidence. Exploring the Benefits of OCT

Watch our latest webinar with Drs. Amani Jambhekar, Jennifer Tittensor, and Catherine A. Ronaghan to learn more about how Optical Coherence Tomography (OCT) can help bring surgeons real-time clarity to make confident decisions in the OR.

Featured

News
Perimeter announces the submission of a Premarket Approval application to the U.S. Food and Drug Administration for the Company's next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence technology with optical coherence tomography, for use during breast-conserving surgeries in the United States.
News
Perimeter announces that detailed results from the pivotal trial evaluating the use of its next-generation B-Series OCT with ImgAssist AI 2.0 during breast-conserving surgeries will be presented during the scientific session of the 26th Annual Meeting of the American Society of Breast Surgeons taking place in Las Vegas, NV, April 30 - May 4, 2025.
WHITE PAPER
This paper comprehensively analyzes current reoperation rates for breast-conserving surgery patients and their associated implications, underscoring the need for new strategies and technologies to address this problem.
View All

Ready to connect with
Perimeter?

Get Started

Continue Exploring

Products

Benefits to Surgeons

See It In Action

Ready to learn more about Perimeter?

Get Started